搜尋結果
Lilly Raises 2024 Guidance as Zepbound Flies Off Shelves
Bloomberg· 2 日前... after it raised its annual guidance on soaring demand for its blockbuster weight ... ...
Forbes Daily: Weed Stocks Light Up After DEA Reclassification
Forbes· 1 日前Home prices across the U.S. rose by 6.4% in February from the previous year, the fastest growth ...
Council Post: Mind Over Money: How Behavioral Finance Shapes Investment Decisions
Forbes· 7 小時前Investing can be exciting and rewarding, but it can also be fraught with psychological pitfalls ...
As Their Clinics Sputter, Walgreens And Walmart Invest More In Specialty Pharmacy
Forbes· 1 日前As Walgreens and Walmart scale back their investments in physician-staffed health clinics, they ...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 1 日前The company affirmed its full-year 2024 guidance of $58.5 billion to $61.5 billion in sales and ...
Stocks making the biggest moves midday: Eli Lilly, 3M, PayPal, Tesla and more
CNBC· 2 日前These were some of the stocks making the largest moves in trading on Tuesday.
Molson Coors Says ‘Volatile Times,’ Not Ozempic, Dim Its Beer Outlook
Bloomberg· 2 日前Have a confidential tip for our reporters? Molson Coors Brewing Co.’s more cautious outlook for ...
Ozempic Frenzy Gives Novo Nordisk ‘Superpowers’ in Denmark
Bloomberg· 21 小時前NewsletterThe Big TakeOzempic Frenzy Gives Novo Nordisk ‘Superpowers’ in DenmarkGift this ...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 1 日前Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its ...
One dose of Novo Nordisk's Wegovy back in supply, FDA website shows
Reuters· 3 日前The website listed the 1.7 milligram (mg) dose as available — making that and the 2.4 mg dose ...